Laboratory of Cellular and Molecular Mechanisms of Histogenesis, Koltsov Institute of Developmental Biology, Moscow, Russia.
Laboratory of Biotechnology, Department of Immunology, Central Tuberculosis Research Institute, Moscow, Russia.
Front Immunol. 2019 May 8;10:972. doi: 10.3389/fimmu.2019.00972. eCollection 2019.
Efficient tuberculosis (TB) control depends on early TB prediction and prevention. Solution to these tasks requires knowledge of TB protection correlates (TB CoPs), i.e., laboratory markers that are mechanistically involved in the protection and which allow to determine how well an individual is protected against TB or how efficient the candidate TB vaccine is. The search for TB CoPs has been largely focused on different T-helper populations, however, the data are controversial, and no reliable CoPs are still known. Here we discuss the role of different T-helper populations in TB protection focusing predominantly on Th17, "non-classical" Th1 (Th1) and "classical" Th1 (cTh1) populations. We analyze how these populations differ besides their effector activity and suggest the hypothesis that: (i) links the protective potential of Th17, Th1, and cTh1 to their differentiation degree and plasticity; (ii) implies different roles of these populations in response to vaccination, latent TB infection (LTBI), and active TB. One of the clinically relevant outcomes of this hypothesis is that over-stimulating T cells during vaccination and biasing T cell response toward the preferential generation of Th1 are not beneficial. The review sheds new light on the problem of TB CoPs and will help develop better strategies for TB control.
有效的结核病 (TB) 控制取决于早期 TB 预测和预防。解决这些任务需要了解结核病保护相关因素 (TB CoPs),即与保护机制相关的实验室标志物,这些标志物可用于确定个体对 TB 的保护程度或候选 TB 疫苗的有效性如何。寻找 TB CoPs 的工作主要集中在不同的 T 辅助细胞群上,但数据存在争议,目前仍未确定可靠的 CoPs。本文主要聚焦于 Th17、“非经典” Th1 (Th1) 和“经典” Th1 (cTh1) 群体,讨论了不同 T 辅助细胞群在 TB 保护中的作用。我们分析了这些群体除了效应器活性之外的差异,并提出了以下假设:(i) 将 Th17、Th1 和 cTh1 的保护潜力与其分化程度和可塑性联系起来;(ii) 意味着这些群体在接种疫苗、潜伏性 TB 感染 (LTBI) 和活动性 TB 中的作用不同。这一假设的一个临床相关结果是,在接种疫苗期间过度刺激 T 细胞并使 T 细胞反应偏向于优先产生 Th1 并不有益。本文对 TB CoPs 问题进行了新的探讨,将有助于制定更好的 TB 控制策略。